Next-generation sequencing of ENKTL and aggressive NK-cell leukemia (ANKL) has shown recurrent mutations in the JAK/STAT pathway, particularly in STAT3 and STAT5B in both lymphoma entities. This evidence concerns the gene SOAT1 and lymphoma.